Skip to content

Study · Not a test of the peptide alone · 1998

3 results

[The efficacy of using thymalin and plasmapheresis in the combined treatment of patients with chronic lympholeukemia].

Tretiak NN, Babenko TF, Gaĭdukova SN, Zverkova AS, Beschastnaia SP

Likars'ka sprava1 Mar 1998

PMID9670669 (opens in a new tab)PepBankPUB-09670669
Publisher pageAsk about this study
Jump to 3 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study3

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone3

In this study, Thymalin was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Thymalin.

  1. 01HumanNot a test of Thymalin aloneNon-randomized trialEfficacy outcome

    In chronic lymphoid leukemia, treatment including thymalin and plasmapheresis shortened time to clinical compensation compared with chemotherapy alone.

    In plain wordsIn chronic lymphoid leukemia, treatment with thymalin and plasmapheresis achieved clinical compensation sooner than chemotherapy alone.

    Peptide
    Thymalin
    Outcome
    DecreaseTime to clinical compensation
    Study

    n: not reported in source

    Comparator
    chemotherapeutic agents only
    Outcome group
    Cancer treatment response · Cancer

    Source sentences

    Summary
    Results are submitted of study of the effectiveness of inclusion into the treatment program for patients with chronic lymphoid leukemia of specific (thymalin) and unspecific (plasmapheresis) means and modes of immune correction, which made for more rapid attaining clinical and hematological compensa…
    1 context sentence
    Title · context
    [The efficacy of using thymalin and plasmapheresis in the combined treatment of patients with chronic lympholeukemia].

    In this study, Thymalin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymalin.

  2. 02HumanNot a test of Thymalin aloneNon-randomized trialEfficacy outcome

    In chronic lymphoid leukemia, treatment including thymalin and plasmapheresis shortened time to hematological compensation compared with chemotherapy alone.

    In plain wordsIn chronic lymphoid leukemia, treatment with thymalin and plasmapheresis achieved blood-related compensation sooner than chemotherapy alone.

    Peptide
    Thymalin
    Outcome
    DecreaseTime to hematological compensation
    Study

    n: not reported in source

    Comparator
    chemotherapeutic agents only
    Outcome group
    Cancer treatment response · Cancer

    Source sentences

    Summary
    Results are submitted of study of the effectiveness of inclusion into the treatment program for patients with chronic lymphoid leukemia of specific (thymalin) and unspecific (plasmapheresis) means and modes of immune correction, which made for more rapid attaining clinical and hematological compensa…
    1 context sentence
    Title · context
    [The efficacy of using thymalin and plasmapheresis in the combined treatment of patients with chronic lympholeukemia].

    In this study, Thymalin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymalin.

  3. 03HumanNot a test of Thymalin aloneNon-randomized trialEfficacy outcome

    In chronic lymphoid leukemia, combined treatment including thymalin and plasmapheresis improved lymphoid system functional activity.

    In plain wordsIn chronic lymphoid leukemia, combined treatment with thymalin and plasmapheresis improved lymphoid system function.

    Peptide
    Thymalin
    Outcome
    IncreaseLymphoid system functional activity
    Study

    n: not reported in source

    Outcome group
    Immune response · Immune and inflammation

    Source sentences

    Summary
    Furthermore, the method of combined use of drugs, attempted for the first time, permitted the functional activity of the lymphoid system to be improved, with the clinical and hematological compensation being achieved in a shorter space of time.
    1 context sentence
    Title · context
    [The efficacy of using thymalin and plasmapheresis in the combined treatment of patients with chronic lympholeukemia].

    In this study, Thymalin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymalin.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    14 Oct 2026, 05:02 UTC

    Study results updated

  2. Version 1

    14 Oct 2026, 01:46 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.